Benedetta Bolognesi and Ben Lehner win competitive funding to join forces against neurodegenerative diseases 

The “la Caixa” Foundation will fund a large and innovative research project co-led by IBEC Junior Group Leader Benedetta Bolognesi and by ICREA research professor Ben Lehner at CRG, which aims to gain a better understanding of the genetic causes leading to neurodegenerative diseases. Researchers will combine deep mutagenesis and machine learning techniques to produce a “map of dementia” as a method to predict whether a person is more susceptible to suffer these diseases. 

Read more…

Samuel Sánchez’s Nanorobots against cancer will accelerate with support from the “La Caixa” Foundation

Samuel Sánchez and his team at the Institute for Bioengineering of Catalonia (IBEC), earned the competitive call CaixaResearch for Health Research to develop nanorobots against bladder cancer. Sánchez, a pioneer in the field of self-propelled nanorobots, proposes to move in this way towards solutions against one of the most common, recurring and expensive forms of cancer to treat.

Read more…

The heroes of the pandemic and their experience at IBEC, in tribute to the victims of COVID19

The brilliant medical student, Laia Marcos, has been one of the protagonists of the tribute broadcast by TVE to the victims of COVID19 that took place today at the Royal Palace. Marcos lived a decisive step in her life, during hher stay in the laboratory of the pioneer researcher Samuel Sánchez at IBEC, with the help of the also scientific and expert Maria Guix.

Read more…

The art of explaining bioengineering in images

The Institute for Bioengineering of Catalonia (IBEC) participates for the second consecutive time in the initiative “Creative Talent and Business” promoted by the Generalitat of Catalonia. IBEC, which is the first research centre to participate in this program, plans to annually renew its participation in this initiative, posing a different challenge for each academic year.

Read more…

Nuria Montserrat, invited as a key speaker at the European Research and Innovation Days

Last 23rd and 24th of June took place the European Research and Innovation Days, where Nuria Montserrat was invited to share her research and personal experiences in a high-level panel about “COVID-19: lessons learnt, preparedness and resilience”. The event was opened by Mariya Gabriel, European Commissioner for Innovation, Research, Culture, Education and Youth and was moderated chaired by Philip Campbell, Editor-in-Chief Springer Nature.

Read more…

Nuria Montserrat wins the National Research Award for Young Talent 

Nuria Montserrat, ICREA Research Professor and Group Leader at IBEC, has been awarded the National Research Award for Young Talent 2020 by the Catalan Government and the Catalan Foundation for Research and Innovation (FCRi). This award recognizes the pioneering research of Professor Montserrat in the field of bioengineering of pluripotent cells and generation of organoids, also known as mini-organs, for the study of diseases in humans. 

Read more…

IBEC researchers win two “BIST Ignite Seed Grants”

IBEC researchers receive two “Ignite Seed Grants” to combine their skills with other BIST members to seek scientific answers to health challenges. Benedetta Bolognesi will study, with the IRB, Huntington’s disease and other neurodegenerative pathologies without treatment. On the other hand, Juan Manuel Fernández-Costa and researchers at ICFO will develop muscles-on-a-chip and biomagnetism sensors to accelerate the design of new treatments for muscular dystrophy.

Read more…

IBEC promotes the development of advanced therapies thanks to FEDER funding

Funding from the 2014-2020 Catalan FEDER Operational Program, through the call for institutional projects for R+D infrastructure with a total amount of 700,000€, has co-financed the adaptation of new laboratory spaces and the acquisition of scientific equipment for IBEC laboratories. These new infrastructures will be aimed at boosting nanomedicine and tissue engineering research for the development of advanced therapies.

Read more…